George V. Rebec - Publications

Affiliations: 
Indiana University, Bloomington, Bloomington, IN, United States 
Area:
neurodegenerative disease, drug addiction

196 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Estrada-Sánchez AM, Rangel-Barajas C, Howe AG, Barton SJ, Mach RH, Luedtke RR, Rebec GV. Selective Activation of D3 Dopamine Receptors Ameliorates DOI-Induced Head Twitching Accompanied by Changes in Corticostriatal Processing. International Journal of Molecular Sciences. 24. PMID 37298250 DOI: 10.3390/ijms24119300  0.363
2020 Ponzi A, Barton SJ, Bunner KD, Rangel-Barajas C, Zhang ES, Miller BR, Rebec GV, Kozloski J. Striatal network modeling in Huntington's Disease. Plos Computational Biology. 16: e1007648. PMID 32302302 DOI: 10.1371/journal.pcbi.1007648  0.529
2019 Estrada-Sanchez AM, Blake CL, Barton SJ, Howe AG, Rebec GV. Lack of mutant huntingtin in cortical efferents improves behavioral inflexibility and corticostriatal dynamics in Huntington's disease mice. Journal of Neurophysiology. PMID 31693428 DOI: 10.1152/jn.00777.2018  0.35
2019 Ballaz SJ, Rebec GV. Neurobiology of vitamin C: Expanding the focus from antioxidant to endogenous neuromodulator. Pharmacological Research. 146: 104321. PMID 31229562 DOI: 10.1016/j.phrs.2019.104321  0.326
2018 Rangel-Barajas C, Rebec GV. Overview of Huntington's Disease Models: Neuropathological, Molecular, and Behavioral Differences. Current Protocols in Neuroscience. 83: e47. PMID 30040221 DOI: 10.1002/cpns.47  0.324
2018 Rebec GV. Corticostriatal network dysfunction in huntington's disease: Deficits in neural processing, glutamate transport, and ascorbate release. Cns Neuroscience & Therapeutics. PMID 29464896 DOI: 10.1111/cns.12828  0.375
2018 Cheng H, Kellar D, Lake A, Finn P, Rebec GV, Dharmadhikari S, Dydak U, Newman S. Effects of Alcohol Cues on MRS Glutamate Levels in the Anterior Cingulate. Alcohol and Alcoholism (Oxford, Oxfordshire). PMID 29329417 DOI: 10.1093/Alcalc/Agx119  0.302
2016 Rangel-Barajas C, Rebec GV. Dysregulation of Corticostriatal Connectivity in Huntington's Disease: A Role for Dopamine Modulation. Journal of Huntington's Disease. 5: 303-331. PMID 27983564 DOI: 10.3233/JHD-160221  0.449
2016 Rangel-Barajas C, Estrada-Sánchez AM, Barton SJ, Luedtke RR, Rebec GV. Dysregulated corticostriatal activity in open-field behavior and the head-twitch response induced by the hallucinogen 2,5-dimethoxy-4-iodoamphetamine. Neuropharmacology. PMID 27816502 DOI: 10.1016/j.neuropharm.2016.11.001  0.452
2016 Bunner KD, Rebec GV. Corticostriatal Dysfunction in Huntington's Disease: The Basics. Frontiers in Human Neuroscience. 10: 317. PMID 27445757 DOI: 10.3389/fnhum.2016.00317  0.467
2016 Nakhnikian A, Ito S, Dwiel LL, Grasse LM, Rebec GV, Lauridsen LN, Beggs JM. A Novel Cross-Frequency Coupling Detection Method Using the Generalized Morse Wavelets. Journal of Neuroscience Methods. PMID 27129446 DOI: 10.1016/J.Jneumeth.2016.04.019  0.73
2016 Hong SL, Estrada-Sánchez AM, Barton SJ, Rebec GV. Early Exposure to Dynamic Environments Alters Patterns of Motor Exploration throughout the Lifespan. Behavioural Brain Research. PMID 26778790 DOI: 10.1016/j.bbr.2016.01.007  0.336
2015 Estrada-Sánchez AM, Burroughs CL, Cavaliere S, Barton SJ, Chen S, Yang XW, Rebec GV. Cortical efferents lacking mutant huntingtin improve striatal neuronal activity and behavior in a conditional mouse model of Huntington's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 35: 4440-51. PMID 25762686 DOI: 10.1523/JNEUROSCI.2812-14.2015  0.346
2014 Sunsay C, Rebec GV. Extinction and reinstatement of phasic dopamine signals in the nucleus accumbens core during Pavlovian conditioning. Behavioral Neuroscience. 128: 579-87. PMID 25111335 DOI: 10.1037/bne0000012  0.382
2014 Nakhnikian A, Rebec GV, Grasse LM, Dwiel LL, Shimono M, Beggs JM. Behavior modulates effective connectivity between cortex and striatum. Plos One. 9: e89443. PMID 24618981 DOI: 10.1371/Journal.Pone.0089443  0.789
2014 Rebec GV. Vitamin C and Glutamate Uptake: Implications for Huntington's Disease Diet and Nutrition in Dementia and Cognitive Decline. 669-678. DOI: 10.1016/B978-0-12-407824-6.00062-8  0.363
2014 Estrada-Sánchez AM, Bunner KD, Rebec GV. Huntington's Disease and Dementia: From Transgenic Models to Molecular Neuropathology Diet and Nutrition in Dementia and Cognitive Decline. 77-90. DOI: 10.1016/B978-0-12-407824-6.00008-2  0.303
2013 Estrada-Sánchez AM, Barton SJ, Rebec GV. Altered Neuronal Dynamics in the Striatum on the Behavior of Huntingtin Interacting Protein 14 (HIP14) Knockout Mice. Brain Sciences. 3: 1588-96. PMID 24961622 DOI: 10.3390/brainsci3041588  0.43
2013 Estrada-Sánchez AM, Barton SJ, Burroughs CL, Doyle AR, Rebec GV. Dysregulated striatal neuronal processing and impaired motor behavior in mice lacking huntingtin interacting protein 14 (HIP14). Plos One. 8: e84537. PMID 24376823 DOI: 10.1371/journal.pone.0084537  0.442
2013 Fischer KD, Houston AC, Rebec GV. Role of the major glutamate transporter GLT1 in nucleus accumbens core versus shell in cue-induced cocaine-seeking behavior. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 9319-27. PMID 23719800 DOI: 10.1523/Jneurosci.3278-12.2013  0.643
2013 Rebec GV. Dysregulation of corticostriatal ascorbate release and glutamate uptake in transgenic models of Huntington's disease. Antioxidants & Redox Signaling. 19: 2115-28. PMID 23642110 DOI: 10.1089/ars.2013.5387  0.433
2013 Estrada-Sánchez AM, Rebec GV. Role of cerebral cortex in the neuropathology of Huntington's disease. Frontiers in Neural Circuits. 7: 19. PMID 23423362 DOI: 10.3389/fncir.2013.00019  0.42
2012 Hong SL, Rebec GV. Biological sources of inflexibility in brain and behavior with aging and neurodegenerative diseases. Frontiers in Systems Neuroscience. 6: 77. PMID 23226117 DOI: 10.3389/fnsys.2012.00077  0.329
2012 Hong SL, Cossyleon D, Hussain WA, Walker LJ, Barton SJ, Rebec GV. Dysfunctional behavioral modulation of corticostriatal communication in the R6/2 mouse model of Huntington's disease. Plos One. 7: e47026. PMID 23056565 DOI: 10.1371/journal.pone.0047026  0.406
2012 Hong SL, Rebec GV. A new perspective on behavioral inconsistency and neural noise in aging: compensatory speeding of neural communication. Frontiers in Aging Neuroscience. 4: 27. PMID 23055970 DOI: 10.3389/fnagi.2012.00027  0.306
2012 Estrada-Sánchez AM, Rebec GV. Corticostriatal dysfunction and glutamate transporter 1 (GLT1) in Huntington's disease: interactions between neurons and astrocytes. Basal Ganglia. 2: 57-66. PMID 22905336 DOI: 10.1016/j.baga.2012.04.029  0.417
2012 Hong SL, Barton SJ, Rebec GV. Neural correlates of unpredictability in behavioral patterns of wild-type and R6/2 mice. Communicative & Integrative Biology. 5: 259-61. PMID 22896787 DOI: 10.4161/cib.19782  0.34
2012 Fischer-Smith KD, Houston AC, Rebec GV. Differential effects of cocaine access and withdrawal on glutamate type 1 transporter expression in rat nucleus accumbens core and shell. Neuroscience. 210: 333-9. PMID 22433294 DOI: 10.1016/j.neuroscience.2012.02.049  0.37
2012 Miller BR, Dorner JL, Bunner KD, Gaither TW, Klein EL, Barton SJ, Rebec GV. Up-regulation of GLT1 reverses the deficit in cortically evoked striatal ascorbate efflux in the R6/2 mouse model of Huntington's disease. Journal of Neurochemistry. 121: 629-38. PMID 22332910 DOI: 10.1111/J.1471-4159.2012.07691.X  0.767
2012 Murphy-Nakhnikian A, Dorner JL, Fischer BI, Bower-Bir ND, Rebec GV. Abnormal burst patterns of single neurons recorded in the substantia nigra reticulata of behaving 140 CAG Huntington's disease mice. Neuroscience Letters. 512: 1-5. PMID 22327034 DOI: 10.1016/J.Neulet.2011.12.040  0.74
2012 Hong SL, Barton SJ, Rebec GV. Altered neural and behavioral dynamics in Huntington's disease: an entropy conservation approach. Plos One. 7: e30879. PMID 22292068 DOI: 10.1371/journal.pone.0030879  0.408
2012 Lu L, Xue Y, Steketee JD, Rebec GV, Sun W. Regulation of cocaine-induced reinstatement by group II metabotropic glutamate receptors in the ventral tegmental area. Psychopharmacology. 220: 75-85. PMID 21881873 DOI: 10.1007/s00213-011-2455-5  0.4
2011 Miller BR, Walker AG, Barton SJ, Rebec GV. Dysregulated Neuronal Activity Patterns Implicate Corticostriatal Circuit Dysfunction in Multiple Rodent Models of Huntington's Disease. Frontiers in Systems Neuroscience. 5: 26. PMID 21629717 DOI: 10.3389/fnsys.2011.00026  0.762
2011 Walker AG, Ummel JR, Rebec GV. Reduced expression of conditioned fear in the R6/2 mouse model of Huntington's disease is related to abnormal activity in prelimbic cortex. Neurobiology of Disease. 43: 379-87. PMID 21515374 DOI: 10.1016/j.nbd.2011.04.009  0.676
2011 Sari Y, Sakai M, Weedman JM, Rebec GV, Bell RL. Ceftriaxone, a beta-lactam antibiotic, reduces ethanol consumption in alcohol-preferring rats. Alcohol and Alcoholism (Oxford, Oxfordshire). 46: 239-46. PMID 21422004 DOI: 10.1093/Alcalc/Agr023  0.322
2011 Wood DA, Walker TL, Rebec GV. Experience-dependent changes in neuronal processing in the nucleus accumbens shell in a discriminative learning task in differentially housed rats. Brain Research. 1390: 90-8. PMID 21420938 DOI: 10.1016/j.brainres.2011.03.023  0.425
2011 Xue Y, Steketee JD, Rebec GV, Sun W. Activation of Dâ‚‚-like receptors in rat ventral tegmental area inhibits cocaine-reinstated drug-seeking behavior. The European Journal of Neuroscience. 33: 1291-8. PMID 21261759 DOI: 10.1111/j.1460-9568.2010.07591.x  0.452
2011 Wilber AA, Walker AG, Southwood CJ, Farrell MR, Lin GL, Rebec GV, Wellman CL. Chronic stress alters neural activity in medial prefrontal cortex during retrieval of extinction. Neuroscience. 174: 115-31. PMID 21044660 DOI: 10.1016/J.Neuroscience.2010.10.070  0.673
2010 Ball KT, Wellman CL, Miller BR, Rebec GV. Electrophysiological and structural alterations in striatum associated with behavioral sensitization to (±)3,4-methylenedioxymethamphetamine (Ecstasy) in rats: role of drug context. Neuroscience. 171: 794-811. PMID 20875842 DOI: 10.1016/J.Neuroscience.2010.09.041  0.768
2010 Sari Y, Prieto AL, Barton SJ, Miller BR, Rebec GV. Ceftriaxone-induced up-regulation of cortical and striatal GLT1 in the R6/2 model of Huntington's disease. Journal of Biomedical Science. 17: 62. PMID 20663216 DOI: 10.1186/1423-0127-17-62  0.542
2010 Rebec GV. A central role for the periphery in the rapid action of cocaine on brain neurons: focus on "Rapid EEG desynchronization and EMG activation induced by intravenous cocaine in freely moving rats: a peripheral, nondopamine neural triggering". American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. 298: R283-4. PMID 20007514 DOI: 10.1152/ajpregu.00795.2009  0.343
2010 Miller BR, Walker AG, Fowler SC, von Hörsten S, Riess O, Johnson MA, Rebec GV. Dysregulation of coordinated neuronal firing patterns in striatum of freely behaving transgenic rats that model Huntington's disease. Neurobiology of Disease. 37: 106-13. PMID 19818852 DOI: 10.1016/J.Nbd.2009.09.013  0.763
2009 Sari Y, Smith KD, Ali PK, Rebec GV. Upregulation of GLT1 attenuates cue-induced reinstatement of cocaine-seeking behavior in rats. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 9239-43. PMID 19625514 DOI: 10.1523/JNEUROSCI.1746-09.2009  0.393
2009 Dorner JL, Miller BR, Klein EL, Murphy-Nakhnikian A, Andrews RL, Barton SJ, Rebec GV. Corticostriatal dysfunction underlies diminished striatal ascorbate release in the R6/2 mouse model of Huntington's disease. Brain Research. 1290: 111-20. PMID 19616518 DOI: 10.1016/J.Brainres.2009.07.019  0.764
2009 Fowler SC, Miller BR, Gaither TW, Johnson MA, Rebec GV. Force-plate quantification of progressive behavioral deficits in the R6/2 mouse model of Huntington's disease. Behavioural Brain Research. 202: 130-7. PMID 19447289 DOI: 10.1016/J.Bbr.2009.03.022  0.517
2009 Ball KT, Wellman CL, Fortenberry E, Rebec GV. Sensitizing regimens of (+/-)3, 4-methylenedioxymethamphetamine (ecstasy) elicit enduring and differential structural alterations in the brain motive circuit of the rat. Neuroscience. 160: 264-74. PMID 19236907 DOI: 10.1016/J.Neuroscience.2009.02.025  0.722
2009 Wood DA, Rebec GV. Environmental enrichment alters neuronal processing in the nucleus accumbens core during appetitive conditioning. Brain Research. 1259: 59-67. PMID 19135429 DOI: 10.1016/j.brainres.2008.12.038  0.413
2008 Walker AG, Miller BR, Fritsch JN, Barton SJ, Rebec GV. Altered information processing in the prefrontal cortex of Huntington's disease mouse models. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 8973-82. PMID 18768691 DOI: 10.1523/JNEUROSCI.2804-08.2008  0.74
2008 Miller BR, Walker AG, Shah AS, Barton SJ, Rebec GV. Dysregulated information processing by medium spiny neurons in striatum of freely behaving mouse models of Huntington's disease. Journal of Neurophysiology. 100: 2205-16. PMID 18667541 DOI: 10.1152/jn.90606.2008  0.743
2008 Sunsay C, Rebec GV. Real-time dopamine efflux in the nucleus accumbens core during Pavlovian conditioning. Behavioral Neuroscience. 122: 358-67. PMID 18410174 DOI: 10.1037/0735-7044.122.2.358  0.402
2008 Miller BR, Dorner JL, Shou M, Sari Y, Barton SJ, Sengelaub DR, Kennedy RT, Rebec GV. Up-regulation of GLT1 expression increases glutamate uptake and attenuates the Huntington's disease phenotype in the R6/2 mouse. Neuroscience. 153: 329-37. PMID 18353560 DOI: 10.1016/J.Neuroscience.2008.02.004  0.756
2007 Liu X, Miller BR, Rebec GV, Clemmer DE. Protein expression in the striatum and cortex regions of the brain for a mouse model of Huntington's disease. Journal of Proteome Research. 6: 3134-42. PMID 17625815 DOI: 10.1021/Pr070092S  0.503
2007 Ball KT, Walsh KM, Rebec GV. Reinstatement of MDMA (ecstasy) seeking by exposure to discrete drug-conditioned cues. Pharmacology, Biochemistry, and Behavior. 87: 420-5. PMID 17602729 DOI: 10.1016/J.Pbb.2007.05.018  0.638
2007 Sandstrom MI, Rebec GV. Extracellular ascorbate modulates glutamate dynamics: role of behavioral activation. Bmc Neuroscience. 8: 32. PMID 17506898 DOI: 10.1186/1471-2202-8-32  0.392
2007 Dorner JL, Miller BR, Barton SJ, Brock TJ, Rebec GV. Sex differences in behavior and striatal ascorbate release in the 140 CAG knock-in mouse model of Huntington's disease. Behavioural Brain Research. 178: 90-7. PMID 17239451 DOI: 10.1016/J.Bbr.2006.12.004  0.754
2007 Teagarden MA, Rebec GV. Subthalamic and striatal neurons concurrently process motor, limbic, and associative information in rats performing an operant task. Journal of Neurophysiology. 97: 2042-58. PMID 17182916 DOI: 10.1152/Jn.00368.2006  0.806
2006 Ball KT, Budreau D, Rebec GV. Context-dependent behavioural and neuronal sensitization in striatum to MDMA (ecstasy) administration in rats. The European Journal of Neuroscience. 24: 217-28. PMID 16882018 DOI: 10.1111/J.1460-9568.2006.04885.X  0.723
2006 Sun W, Rebec GV. Repeated cocaine self-administration alters processing of cocaine-related information in rat prefrontal cortex. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 8004-8. PMID 16870745 DOI: 10.1523/JNEUROSCI.1413-06.2006  0.362
2006 Rebec GV. Behavioral electrophysiology of psychostimulants. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 2341-8. PMID 16855534 DOI: 10.1038/sj.npp.1301160  0.544
2006 Cortright JJ, Rebec GV. Ascorbate modulation of sensorimotor processing in striatum of freely moving rats. Brain Research. 1092: 108-16. PMID 16753136 DOI: 10.1016/J.Brainres.2006.03.079  0.84
2006 Wood DA, Siegel AK, Rebec GV. Environmental enrichment reduces impulsivity during appetitive conditioning. Physiology & Behavior. 88: 132-7. PMID 16678224 DOI: 10.1016/j.physbeh.2006.03.024  0.349
2006 Rebec GV, Conroy SK, Barton SJ. Hyperactive striatal neurons in symptomatic Huntington R6/2 mice: variations with behavioral state and repeated ascorbate treatment. Neuroscience. 137: 327-36. PMID 16257492 DOI: 10.1016/J.Neuroscience.2005.08.062  0.459
2005 Rebec GV, Sun W. Neuronal substrates of relapse to cocaine-seeking behavior: role of prefrontal cortex. Journal of the Experimental Analysis of Behavior. 84: 653-66. PMID 16596984 DOI: 10.1901/jeab.2005.105-04  0.408
2005 Ball KT, Rebec GV. Role of 5-HT2A and 5-HT2C/B receptors in the acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on striatal single-unit activity and locomotion in freely moving rats. Psychopharmacology. 181: 676-87. PMID 16001122 DOI: 10.1007/S00213-005-0038-Z  0.725
2005 Wood DA, Buse JE, Wellman CL, Rebec GV. Differential environmental exposure alters NMDA but not AMPA receptor subunit expression in nucleus accumbens core and shell. Brain Research. 1042: 176-83. PMID 15854589 DOI: 10.1016/J.Brainres.2005.02.029  0.4
2005 Sun W, Akins CK, Mattingly AE, Rebec GV. Ionotropic glutamate receptors in the ventral tegmental area regulate cocaine-seeking behavior in rats. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 30: 2073-81. PMID 15841101 DOI: 10.1038/Sj.Npp.1300744  0.442
2005 Rebec GV, Witowski SR, Sandstrom MI, Rostand RD, Kennedy RT. Extracellular ascorbate modulates cortically evoked glutamate dynamics in rat striatum. Neuroscience Letters. 378: 166-70. PMID 15781152 DOI: 10.1016/J.Neulet.2004.12.027  0.396
2005 Sun W, Rebec GV. The role of prefrontal cortex D1-like and D2-like receptors in cocaine-seeking behavior in rats. Psychopharmacology. 177: 315-23. PMID 15309375 DOI: 10.1007/s00213-004-1956-x  0.395
2004 Garris PA, Ensman R, Poehlman J, Alexander A, Langley PE, Sandberg SG, Greco PG, Wightman RM, Rebec GV. Wireless transmission of fast-scan cyclic voltammetry at a carbon-fiber microelectrode: proof of principle. Journal of Neuroscience Methods. 140: 103-15. PMID 15589340 DOI: 10.1016/j.jneumeth.2004.04.043  0.336
2004 Wood DA, Kosobud AE, Rebec GV. Nucleus accumbens single-unit activity in freely behaving male rats during approach to novel and non-novel estrus. Neuroscience Letters. 368: 29-32. PMID 15342128 DOI: 10.1016/j.neulet.2004.06.051  0.349
2004 Gulley JM, Reed JL, Kuwajima M, Rebec GV. Amphetamine-induced behavioral activation is associated with variable changes in basal ganglia output neurons recorded from awake, behaving rats. Brain Research. 1012: 108-18. PMID 15158167 DOI: 10.1016/J.Brainres.2004.03.044  0.781
2004 Wood DA, Rebec GV. Dissociation of core and shell single-unit activity in the nucleus accumbens in free-choice novelty. Behavioural Brain Research. 152: 59-66. PMID 15135969 DOI: 10.1016/j.bbr.2003.09.038  0.445
2003 Ball KT, Budreau D, Rebec GV. Acute effects of 3,4-methylenedioxymethamphetamine on striatal single-unit activity and behavior in freely moving rats: differential involvement of dopamine D(1) and D(2) receptors. Brain Research. 994: 203-15. PMID 14642646 DOI: 10.1016/J.Brainres.2003.09.037  0.762
2003 Sun W, Rebec GV. Lidocaine inactivation of ventral subiculum attenuates cocaine-seeking behavior in rats. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 10258-64. PMID 14614084 DOI: 10.1523/Jneurosci.23-32-10258.2003  0.342
2003 Rebec GV, Barton SJ, Marseilles AM, Collins K. Ascorbate treatment attenuates the Huntington behavioral phenotype in mice. Neuroreport. 14: 1263-5. PMID 12824772 DOI: 10.1097/01.wnr.0000081868.45938.12  0.418
2003 Garris PA, Budygin EA, Phillips PE, Venton BJ, Robinson DL, Bergstrom BP, Rebec GV, Wightman RM. A role for presynaptic mechanisms in the actions of nomifensine and haloperidol. Neuroscience. 118: 819-29. PMID 12710989 DOI: 10.1016/S0306-4522(03)00005-8  0.491
2003 Sandstrom MI, Rebec GV. Characterization of striatal activity in conscious rats: contribution of NMDA and AMPA/kainate receptors to both spontaneous and glutamate-driven firing. Synapse (New York, N.Y.). 47: 91-100. PMID 12454946 DOI: 10.1002/syn.10142  0.464
2002 Garris PA, Rebec GV. Modeling fast dopamine neurotransmission in the nucleus accumbens during behavior. Behavioural Brain Research. 137: 47-63. PMID 12445715 DOI: 10.1016/S0166-4328(02)00284-X  0.483
2002 Gulley JM, Kosobud AE, Rebec GV. Behavior-related modulation of substantia nigra pars reticulata neurons in rats performing a conditioned reinforcement task. Neuroscience. 111: 337-49. PMID 11983319 DOI: 10.1016/S0306-4522(02)00018-0  0.739
2002 Gulley JM, Kosobud AE, Rebec GV. Amphetamine inhibits behavior-related neuronal responses in substantia nigra pars reticulata of rats working for sucrose reinforcement. Neuroscience Letters. 322: 165-8. PMID 11897164 DOI: 10.1016/S0304-3940(02)00064-2  0.768
2002 Rebec GV, Barton SJ, Ennis MD. Dysregulation of ascorbate release in the striatum of behaving mice expressing the Huntington's disease gene. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: RC202. PMID 11784814 DOI: 10.1523/Jneurosci.22-02-J0006.2002  0.435
2001 Tinsley MR, Rebec GV, Timberlake W. Facilitation of efficient search of an unbaited radial-arm maze in rats by D1, but not D2, dopamine receptors. Pharmacology, Biochemistry, and Behavior. 70: 181-6. PMID 11701186 DOI: 10.1016/S0091-3057(01)00601-3  0.436
2001 Teagarden MA, Rebec GV. Effects of long-term haloperidol treatment on glutamate-evoked ascorbate release in rat striatum. European Journal of Pharmacology. 418: 213-6. PMID 11343692 DOI: 10.1016/S0014-2999(01)00942-6  0.792
2001 Kiyatkin EA, Rebec GV. Impulse activity of ventral tegmental area neurons during heroin self-administration in rats. Neuroscience. 102: 565-80. PMID 11226694 DOI: 10.1016/S0306-4522(00)00492-9  0.494
2001 Rebec GV, Wang Z. Behavioral activation in rats requires endogenous ascorbate release in striatum. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 21: 668-75. PMID 11160445 DOI: 10.1523/Jneurosci.21-02-00668.2001  0.488
2000 Pecoraro N, Kosobud AE, Rebec GV, Timberlake W. Long T methamphetamine schedules produce circadian ensuing drug activity in rats. Physiology & Behavior. 71: 95-106. PMID 11134691 DOI: 10.1016/S0031-9384(00)00306-1  0.357
2000 Tinsley MR, Rebec GV, Timberlake W. Facilitation of preparatory behavior in an artificial prey paradigm by D1-subfamily dopamine receptor activation. Behavioural Brain Research. 114: 23-30. PMID 10996043 DOI: 10.1016/S0166-4328(00)00188-1  0.449
2000 Heidenreich BA, Rebec GV. Effects of crus cerebri lesions and repeated amphetamine treatment on the activity of nigral dopaminergic neurons. Synapse (New York, N.Y.). 38: 80-6. PMID 10941143 DOI: 10.1002/1098-2396(200010)38:1<80::AID-SYN9>3.0.CO;2-1  0.501
2000 Kiyatkin EA, Kiyatkin DE, Rebec GV. Phasic inhibition of dopamine uptake in nucleus accumbens induced by intravenous cocaine in freely behaving rats. Neuroscience. 98: 729-41. PMID 10891616 DOI: 10.1016/S0306-4522(00)00168-8  0.444
2000 Kiyatkin EA, Rebec GV. Dopamine-independent action of cocaine on striatal and accumbal neurons. The European Journal of Neuroscience. 12: 1789-800. PMID 10792456 DOI: 10.1046/J.1460-9568.2000.00066.X  0.453
2000 Christensen JC, Wang Z, Rebec GV. gamma-Aminobutyric acid infusion in substantia nigra pars reticulata in rats inhibits ascorbate release in ipsilateral striatum. Neuroscience Letters. 280: 191-4. PMID 10675793 DOI: 10.1016/S0304-3940(00)00777-1  0.357
1999 Gulley JM, Kuwajima M, Mayhill E, Rebec GV. Behavior-related changes in the activity of substantia nigra pars reticulata neurons in freely moving rats. Brain Research. 845: 68-76. PMID 10529445 DOI: 10.1016/S0006-8993(99)01932-0  0.772
1999 Gulley JM, Rebec GV. Modulatory effects of ascorbate, alone or with haloperidol, on a lever-release conditioned avoidance response task. Pharmacology, Biochemistry, and Behavior. 63: 125-9. PMID 10340532 DOI: 10.1016/S0091-3057(98)00249-4  0.736
1999 Kiyatkin EA, Rebec GV. Striatal neuronal activity and responsiveness to dopamine and glutamate after selective blockade of D1 and D2 dopamine receptors in freely moving rats. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 19: 3594-609. PMID 10212318 DOI: 10.1523/Jneurosci.19-09-03594.1999  0.541
1999 Kiyatkin EA, Rebec GV. Modulation of striatal neuronal activity by glutamate and GABA: iontophoresis in awake, unrestrained rats. Brain Research. 822: 88-106. PMID 10082887 DOI: 10.1016/S0006-8993(99)01093-8  0.44
1998 White IM, Doubles L, Rebec GV. Cocaine-induced activation of striatal neurons during focused stereotypy in rats. Brain Research. 810: 146-52. PMID 9813293 DOI: 10.1016/S0006-8993(98)00905-6  0.695
1998 Kiyatkin EA, Rebec GV. Ascorbate modulates glutamate-induced excitations of striatal neurons. Brain Research. 812: 14-22. PMID 9813223 DOI: 10.1016/S0006-8993(98)00814-2  0.462
1998 Wang Z, Rebec GV. Neuroethological assessment of amphetamine-induced behavioral changes and their reversal by neuroleptics: focus on the amygdala and nucleus accumbens. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 22: 883-905. PMID 9723126 DOI: 10.1016/S0278-5846(98)00046-3  0.494
1998 Kosobud AE, Pecoraro NC, Rebec GV, Timberlake W. Circadian activity precedes daily methamphetamine injections in the rat. Neuroscience Letters. 250: 99-102. PMID 9697928 DOI: 10.1016/S0304-3940(98)00439-X  0.369
1998 Kiyatkin EA, Rebec GV. Heterogeneity of ventral tegmental area neurons: single-unit recording and iontophoresis in awake, unrestrained rats. Neuroscience. 85: 1285-309. PMID 9681963 DOI: 10.1016/S0306-4522(98)00054-2  0.474
1998 Haracz JL, Tschanz JT, Wang Z, Griffith KE, Rebec GV. Amphetamine effects on striatal neurons: implications for models of dopamine function. Neuroscience and Biobehavioral Reviews. 22: 613-22. PMID 9662723 DOI: 10.1016/S0149-7634(97)00057-2  0.523
1998 Rebec GV. Real-time assessments of dopamine function during behavior: single-unit recording, iontophoresis, and fast-scan cyclic voltammetry in awake, unrestrained rats. Alcoholism, Clinical and Experimental Research. 22: 32-40. PMID 9514283 DOI: 10.1111/J.1530-0277.1998.Tb03614.X  0.534
1998 Rebec GV. Dopamine, glutamate, and behavioral correlates of striatal neuronal activity. Advances in Pharmacology (San Diego, Calif.). 42: 737-40. PMID 9328004 DOI: 10.1016/S1054-3589(08)60853-4  0.526
1997 Hooper KC, Banks DA, Stordahl LJ, White IM, Rebec GV. Quinpirole inhibits striatal and excites pallidal neurons in freely moving rats. Neuroscience Letters. 237: 69-72. PMID 9453217 DOI: 10.1016/S0304-3940(97)00812-4  0.808
1997 Rebec GV, Christensen JR, Guerra C, Bardo MT. Regional and temporal differences in real-time dopamine efflux in the nucleus accumbens during free-choice novelty. Brain Research. 776: 61-7. PMID 9439796 DOI: 10.1016/S0006-8993(97)01004-4  0.444
1997 Kiyatkin EA, Rebec GV. Iontophoresis of amphetamine in the neostriatum and nucleus accumbens of awake, unrestrained rats. Brain Research. 771: 14-24. PMID 9383003 DOI: 10.1016/S0006-8993(97)00689-6  0.532
1997 Kiyatkin EA, Rebec GV. Activity of presumed dopamine neurons in the ventral tegmental area during heroin self-administration. Neuroreport. 8: 2581-5. PMID 9261831 DOI: 10.1097/00001756-199707280-00032  0.521
1997 Rebec GV, White IM, Puotz JK. Responses of neurons in dorsal striatum during amphetamine-induced focused stereotypy. Psychopharmacology. 130: 343-51. PMID 9160850 DOI: 10.1007/s002130050249  0.704
1997 Rebec GV, Grabner CP, Johnson M, Pierce RC, Bardo MT. Transient increases in catecholaminergic activity in medial prefrontal cortex and nucleus accumbens shell during novelty. Neuroscience. 76: 707-14. PMID 9135044 DOI: 10.1016/S0306-4522(96)00382-X  0.556
1997 Garris PA, Christensen JR, Rebec GV, Wightman RM. Real-time measurement of electrically evoked extracellular dopamine in the striatum of freely moving rats. Journal of Neurochemistry. 68: 152-61. PMID 8978721 DOI: 10.1046/J.1471-4159.1997.68010152.X  0.439
1996 Trytek ES, White IM, Schroeder DM, Heidenreich BA, Rebec GV. Localization of motor- and nonmotor-related neurons within the matrix-striosome organization of rat striatum. Brain Research. 707: 221-7. PMID 8919299 DOI: 10.1016/0006-8993(95)01261-3  0.613
1996 Kiyatkin EA, Rebec GV. Dopaminergic modulation of glutamate-induced excitations of neurons in the neostriatum and nucleus accumbens of awake, unrestrained rats. Journal of Neurophysiology. 75: 142-53. PMID 8822548 DOI: 10.1152/Jn.1996.75.1.142  0.522
1996 Kiyatkin EA, Rebec GV. Modulatory action of dopamine on acetylcholine-responsive striatal and accumbal neurons in awake, unrestrained rats. Brain Research. 713: 70-8. PMID 8724977 DOI: 10.1016/0006-8993(95)01487-X  0.516
1996 Wang Z, Rebec GV. Amygdaloid neurons respond to clozapine rather than haloperidol in behaving rats pretreated with intra-amygdaloid amphetamine. Brain Research. 711: 64-72. PMID 8680876 DOI: 10.1016/0006-8993(95)01401-2  0.55
1995 White IM, Flory GS, Hooper KC, Speciale J, Banks DA, Rebec GV. Phencyclidine-induced increases in striatal neuron firing in behaving rats: reversal by haloperidol and clozapine. Journal of Neural Transmission. General Section. 102: 99-112. PMID 8748675 DOI: 10.1007/BF01276506  0.819
1995 Pierce RC, Rowlett JK, Rebec GV, Bardo MT. Ascorbate potentiates amphetamine-induced conditioned place preference and forebrain dopamine release in rats. Brain Research. 688: 21-6. PMID 8542311 DOI: 10.1016/0006-8993(95)00494-B  0.626
1995 Pierce RC, Rebec GV. Iontophoresis in the neostriatum of awake, unrestrained rats: differential effects of dopamine, glutamate and ascorbate on motor- and nonmotor-related neurons. Neuroscience. 67: 313-24. PMID 7675172 DOI: 10.1016/0306-4522(95)00012-8  0.667
1995 White IM, Christensen JR, Flory GS, Miller DW, Rebec GV. Amphetamine, cocaine, and dizocilpine enhance performance on a lever-release, conditioned avoidance response task in rats. Psychopharmacology. 118: 324-31. PMID 7617826 DOI: 10.1007/BF02245962  0.661
1994 Tschanz JT, Griffith KE, Haracz JL, Rebec GV. Cortical lesions attenuate the opposing effects of amphetamine and haloperidol on neostriatal neurons in freely moving rats. European Journal of Pharmacology. 257: 161-7. PMID 8082698 DOI: 10.1016/0014-2999(94)90708-0  0.537
1994 White IM, Rebec GV. Performance on a lever-release, conditioned avoidance response task involves both dopamine D1 and D2 receptors. European Journal of Pharmacology. 253: 167-9. PMID 8013542 DOI: 10.1016/0014-2999(94)90772-2  0.626
1994 Heidenreich BA, Trytek ES, Schroeder DM, Sengelaub DR, Rebec GV. A methodology for determining the patch-matrix compartmental location of extracellular single-unit recordings in the striatum of freely moving rats. Journal of Neuroscience Methods. 52: 169-74. PMID 7967719 DOI: 10.1016/0165-0270(94)90127-9  0.361
1994 Pierce RC, Clemens AJ, Grabner CP, Rebec GV. Amphetamine promotes neostriatal ascorbate release via a nigro-thalamo-cortico-neostriatal loop. Journal of Neurochemistry. 63: 1499-507. PMID 7931303 DOI: 10.1046/J.1471-4159.1994.63041499.X  0.596
1994 White IM, Miller DP, White W, Dike GL, Rebec GV, Steinmetz JE. Neuronal activity in rabbit neostriatum during classical eyelid conditioning. Experimental Brain Research. 99: 179-90. PMID 7925801 DOI: 10.1007/BF00239585  0.63
1994 Pierce RC, Clemens AJ, Shapiro LA, Rebec GV. Repeated treatment with ascorbate or haloperidol, but not clozapine, elevates extracellular ascorbate in the neostriatum of freely moving rats. Psychopharmacology. 116: 103-9. PMID 7862921 DOI: 10.1007/BF02244879  0.641
1994 Rebec GV, Pierce RC. A vitamin as neuromodulator: ascorbate release into the extracellular fluid of the brain regulates dopaminergic and glutamatergic transmission. Progress in Neurobiology. 43: 537-65. PMID 7816935 DOI: 10.1016/0301-0082(94)90052-3  0.627
1993 Rosa-Kenig A, Puotz JK, Rebec GV. The involvement of D1 and D2 dopamine receptors in amphetamine-induced changes in striatal unit activity in behaving rats. Brain Research. 619: 347-51. PMID 8374790 DOI: 10.1016/0006-8993(93)91633-4  0.529
1993 White IM, Rebec GV. Responses of rat striatal neurons during performance of a lever-release version of the conditioned avoidance response task. Brain Research. 616: 71-82. PMID 8358630 DOI: 10.1016/0006-8993(93)90194-R  0.657
1993 Rebec GV, Langley PE, Pierce RC, Wang Z, Heidenreich BA. A simple micromanipulator for multiple uses in freely moving rats: electrophysiology, voltammetry, and simultaneous intracerebral infusions. Journal of Neuroscience Methods. 47: 53-9. PMID 8321014 DOI: 10.1016/0165-0270(93)90021-I  0.503
1993 Wang Z, Rebec GV. Neuronal and behavioral correlates of intrastriatal infusions of amphetamine in freely moving rats. Brain Research. 627: 79-88. PMID 8293307 DOI: 10.1016/0006-8993(93)90751-8  0.545
1993 Pierce RC, Rebec GV. Intraneostriatal administration of glutamate antagonists increases behavioral activation and decreases neostriatal ascorbate via nondopaminergic mechanisms. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 13: 4272-80. PMID 8105039 DOI: 10.1523/Jneurosci.13-10-04272.1993  0.61
1993 Haracz JL, Tschanz JT, Wang Z, White IM, Rebec GV. Striatal single-unit responses to amphetamine and neuroleptics in freely moving rats. Neuroscience and Biobehavioral Reviews. 17: 1-12. PMID 8096071 DOI: 10.1016/S0149-7634(05)80226-X  0.725
1992 Pierce RC, Miller DW, Reising DB, Rebec GV. Unilateral neostriatal kainate, but not 6-OHDA, lesions block dopamine agonist-induced ascorbate release in the neostriatum of freely moving rats. Brain Research. 597: 138-43. PMID 1477726 DOI: 10.1016/0006-8993(92)91515-G  0.622
1992 Wang Z, Haracz JL, Rebec GV. BMY-14802, a sigma ligand and potential antipsychotic drug, reverses amphetamine-induced changes in neostriatal single-unit activity in freely moving rats. Synapse (New York, N.Y.). 12: 312-21. PMID 1361249 DOI: 10.1002/syn.890120408  0.53
1992 Pierce RC, Rebec GV. Dopamine-, NMDA- and sigma-receptor antagonists exert differential effects on basal and amphetamine-induced changes in neostriatal ascorbate and DOPAC in awake, behaving rats. Brain Research. 579: 59-66. PMID 1352478 DOI: 10.1016/0006-8993(92)90741-Q  0.649
1992 White IM, Ciancone MT, Haracz JL, Rebec GV. A lever-release version of the conditioned avoidance response paradigm: effects of haloperidol, clozapine, sulpiride, and BMY-14802. Pharmacology, Biochemistry, and Behavior. 41: 29-35. PMID 1347175 DOI: 10.1016/0091-3057(92)90054-J  0.615
1991 Basse-Tomusk A, Rebec GV. Regional distribution of ascorbate and 3,4-dihydroxyphenylacetic acid (DOPAC) in rat striatum. Brain Research. 538: 29-35. PMID 2018931 DOI: 10.1016/0006-8993(91)90372-3  0.393
1991 Yount SE, Kraft ME, Pierce RC, Langley PE, Rebec GV. Acute and long-term amphetamine treatments alter extracellular ascorbate in neostriatum but not nucleus accumbens of freely moving rats. Life Sciences. 49: 1237-44. PMID 1943438 DOI: 10.1016/0024-3205(91)90136-Y  0.615
1991 Tschanz JT, Haracz JL, Griffith KE, Rebec GV. Bilateral cortical ablations attenuate amphetamine-induced excitations of neostriatal motor-related neurons in freely moving rats. Neuroscience Letters. 134: 127-30. PMID 1815145 DOI: 10.1016/0304-3940(91)90523-V  0.507
1991 Pierce RC, Rowlett JK, Bardo MT, Rebec GV. Chronic ascorbate potentiates the effects of chronic haloperidol on behavioral supersensitivity but not D2 dopamine receptor binding. Neuroscience. 45: 373-8. PMID 1762684 DOI: 10.1016/0306-4522(91)90234-F  0.609
1990 White LK, Maurer M, Kraft ME, Oh C, Rebec GV. Intrastriatal infusions of ascorbate antagonize the behavioral response to amphetamine. Pharmacology, Biochemistry, and Behavior. 36: 485-9. PMID 2377651 DOI: 10.1016/0091-3057(90)90245-D  0.464
1990 Basse-Tomusk A, Rebec GV. Corticostriatal and thalamic regulation of amphetamine-induced ascorbate release in the neostriatum. Pharmacology, Biochemistry, and Behavior. 35: 55-60. PMID 2315370 DOI: 10.1016/0091-3057(90)90204-U  0.379
1990 Wiedemann DJ, Basse-Tomusk A, Wilson RL, Rebec GV, Wightman RM. Interference by DOPAC and ascorbate during attempts to measure drug-induced changes in neostriatal dopamine with Nafion-coated, carbon-fiber electrodes. Journal of Neuroscience Methods. 35: 9-18. PMID 2148961 DOI: 10.1016/0165-0270(90)90089-X  0.403
1990 Pierce RC, Rebec GV. Stimulation of both D1 and D2 dopamine receptors increases behavioral activation and ascorbate release in the neostriatum of freely moving rats. European Journal of Pharmacology. 191: 295-302. PMID 1982267 DOI: 10.1016/0014-2999(90)94161-P  0.621
1989 Heidenreich BA, Rebec GV. Serotonergic dorsal raphe neurons: changes in spontaneous neuronal activity and responsiveness to 5-MeODMT following long-term amphetamine administration. Neuroscience Letters. 103: 81-6. PMID 2779857 DOI: 10.1016/0304-3940(89)90489-8  0.525
1989 Haracz JL, Tschanz JT, Greenberg J, Rebec GV. Amphetamine-induced excitations predominate in single neostriatal neurons showing motor-related activity. Brain Research. 489: 365-8. PMID 2743163 DOI: 10.1016/0006-8993(89)90872-X  0.475
1989 Oh C, Gardiner TW, Rebec GV. Blockade of both D1- and D2-dopamine receptors inhibits amphetamine-induced ascorbate release in the neostriatum. Brain Research. 480: 184-9. PMID 2565749 DOI: 10.1016/0006-8993(89)91581-3  0.437
1988 Tschanz JT, Rebec GV. Atypical antipsychotic drugs block selective components of amphetamine-induced stereotypy. Pharmacology, Biochemistry, and Behavior. 31: 519-22. PMID 3251235 DOI: 10.1016/0091-3057(88)90225-0  0.444
1988 Gardiner TW, Iverson DA, Rebec GV. Heterogeneous responses of neostriatal neurons to amphetamine in freely moving rats. Brain Research. 463: 268-74. PMID 3196918 DOI: 10.1016/0006-8993(88)90399-X  0.52
1988 Rebec GV, Curtis SD. Reciprocal zones of excitation and inhibition in the neostriatum. Synapse (New York, N.Y.). 2: 633-5. PMID 2905538 DOI: 10.1002/syn.890020609  0.432
1988 White LK, Carpenter M, Block M, Basse-Tomusk A, Gardiner TW, Rebec GV. Ascorbate antagonizes the behavioral effects of amphetamine by a central mechanism. Psychopharmacology. 94: 284-7. PMID 2832869 DOI: 10.1007/BF00176860  0.478
1988 Anderson GD, Rebec GV. Clozapine and haloperidol in the amygdaloid complex: differential effects on dopamine transmission with long-term treatment. Biological Psychiatry. 23: 497-506. PMID 2830920 DOI: 10.1016/0006-3223(88)90022-4  0.48
1987 Heidenreich BA, Basse-Tomusk AE, Rebec GV. Serotonergic dorsal raphe neurons: subsensitivity to amphetamine with long-term treatment. Neuropharmacology. 26: 719-24. PMID 3627380 DOI: 10.1016/0028-3908(87)90233-4  0.519
1987 Kuhr WG, Wightman RM, Rebec GV. Dopaminergic neurons: simultaneous measurements of dopamine release and single-unit activity during stimulation of the medial forebrain bundle. Brain Research. 418: 122-8. PMID 3499205 DOI: 10.1016/0006-8993(87)90968-1  0.472
1987 Rebec GV. Electrophysiological pharmacology of amphetamine. Monographs in Neural Sciences. 13: 1-33. PMID 2825001 DOI: 10.1159/000414567  0.417
1986 Kamata K, Wilson RL, Alloway KD, Rebec GV. Multiple amphetamine injections reduce the release of ascorbic acid in the neostriatum of the rat. Brain Research. 362: 331-8. PMID 3942882 DOI: 10.1016/0006-8993(86)90458-0  0.717
1986 Basse-Tomusk A, Rebec GV. Ipsapirone depresses neuronal activity in the dorsal raphe nucleus and the hippocampal formation. European Journal of Pharmacology. 130: 141-3. PMID 3780856 DOI: 10.1016/0014-2999(86)90194-9  0.436
1986 Wilson RL, Kamata K, Wightman RM, Rebec GV. Unilateral, intranigral infusions of amphetamine produce differential, bilateral changes in unit activity and extracellular levels of ascorbate in the neostriatum of the rat. Brain Research. 384: 342-7. PMID 3779385 DOI: 10.1016/0006-8993(86)91170-4  0.483
1986 Anderson GD, Rebec GV. Differential response of amygdaloid neurons to clozapine and haloperidol: effects of repeated administration. Pharmacology, Biochemistry, and Behavior. 24: 1561-6. PMID 3737625 DOI: 10.1016/0091-3057(86)90485-5  0.514
1986 Wilson RL, Kamata K, Bigelow JC, Rebec GV, Wightman RM. Crus cerebri lesions abolish amphetamine-induced ascorbate release in the rat neostriatum. Brain Research. 370: 393-6. PMID 3518863 DOI: 10.1016/0006-8993(86)90501-9  0.423
1985 Basse-Tomusk AE, Rebec GV. Unilateral dopamine depletions attenuate the response of striatal neurons to systemic amphetamine in both hemispheres. Neuroscience. 16: 845-50. PMID 4094695 DOI: 10.1016/0306-4522(85)90098-3  0.538
1985 Rebec GV, Centore JM, White LK, Alloway KD. Ascorbic acid and the behavioral response to haloperidol: implications for the action of antipsychotic drugs. Science (New York, N.Y.). 227: 438-40. PMID 4038426 DOI: 10.1126/Science.4038426  0.675
1985 Kamata K, Rebec GV. Nigral reticulata neurons: potentiation of responsiveness to amphetamine with long-term treatment. Brain Research. 332: 188-93. PMID 3995264 DOI: 10.1016/0006-8993(85)90406-8  0.516
1985 Gardiner TW, Armstrong-James M, Caan AW, Wightman RM, Rebec GV. Modulation of neostriatal activity by iontophoresis of ascorbic acid. Brain Research. 344: 181-5. PMID 2864108 DOI: 10.1016/0006-8993(85)91207-7  0.418
1984 Kamata K, Rebec GV. Long-term amphetamine treatment attenuates or reverses the depression of neuronal activity produced by dopamine agonists in the ventral tegmental area. Life Sciences. 34: 2419-27. PMID 6727576 DOI: 10.1016/0024-3205(84)90431-4  0.508
1984 Kamata K, Rebec GV. Nigral dopaminergic neurons: differential sensitivity to apomorphine following long-term treatment with low and high doses of amphetamine. Brain Research. 321: 147-50. PMID 6498510 DOI: 10.1016/0006-8993(84)90691-7  0.465
1984 Rebec GV. Auto- and postsynaptic dopamine receptors in the central nervous system. Monographs in Neural Sciences. 10: 207-23. PMID 6321971 DOI: 10.1159/000408390  0.353
1984 Kamata K, Rebec GV. Iontophoretic evidence for subsensitivity of postsynaptic dopamine receptors following long-term amphetamine administration. European Journal of Pharmacology. 106: 393-7. PMID 6152219 DOI: 10.1016/0014-2999(84)90727-1  0.51
1984 Rebec GV, Bashore TR. Critical issues in assessing the behavioral effects of amphetamine. Neuroscience and Biobehavioral Reviews. 8: 153-9. PMID 6145135 DOI: 10.1016/0149-7634(84)90030-7  0.409
1984 Alloway KD, Rebec GV. Apomorphine-induced inhibition of neostriatal activity is enhanced by lesions induced by 6-hydroxydopamine but not by long-term administration of amphetamine. Neuropharmacology. 23: 1033-9. PMID 6096755 DOI: 10.1016/0028-3908(84)90125-4  0.736
1983 Kamata K, Rebec GV. Dopaminergic and neostriatal neurons: dose-dependent changes in sensitivity to amphetamine following long-term treatment. Neuropharmacology. 22: 1377-82. PMID 6664466 DOI: 10.1016/0028-3908(83)90227-7  0.495
1983 Rebec GV, Lee EH. Tolerance to amphetamine-induced inhibition of neuronal activity in the central amygdaloid nucleus. Pharmacology, Biochemistry, and Behavior. 19: 219-23. PMID 6634871 DOI: 10.1016/0091-3057(83)90042-4  0.528
1983 Rebec GV, Curtis SD. Reciprocal changes in the firing rate of neostriatal and dorsal raphe neurons following local infusions or systemic injections of D-amphetamine: evidence for neostriatal heterogeneity. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 3: 2240-50. PMID 6631478  0.346
1983 Alloway KD, Rebec GV. Shift from inhibition to excitation in the neostriatum but not in the nucleus accumbens following long-term amphetamine. Brain Research. 273: 71-9. PMID 6616234 DOI: 10.1016/0006-8993(83)91096-X  0.748
1983 Ewing AG, Alloway KD, Curtis SD, Dayton MA, Wightman RM, Rebec GV. Simultaneous electrochemical and unit recording measurements: characterization of the effects of D-amphetamine and ascorbic acid on neostriatal neurons. Brain Research. 261: 101-8. PMID 6301620 DOI: 10.1016/0006-8993(83)91288-X  0.718
1983 Rebec GV, Gelman J, Alloway KD, Bashore TR. Cataleptogenic potency of the antipsychotic drugs is inversely correlated with neuronal activity in the amygdaloid complex of the rat. Pharmacology, Biochemistry, and Behavior. 19: 759-63. PMID 6139828 DOI: 10.1016/0091-3057(83)90076-X  0.713
1982 Rebec GV, Curtis SD, Zimmerman KS. Dorsal raphe neurons: self-inhibition by an amphetamine-induced release of endogenous serotonin. Brain Research. 251: 374-9. PMID 7139334 DOI: 10.1016/0006-8993(82)90757-0  0.477
1982 Rebec GV, Lee EH. Differential subsensitivity of dopaminergic and neostriatal neurons to apomorphine with long-term treatment. Brain Research. 250: 188-92. PMID 7139316 DOI: 10.1016/0006-8993(82)90968-4  0.498
1982 Rebec GV, Peirson EE, McPherson FA, Brugge K. Differential sensitivity to amphetamine following long-term treatment with clozapine or haloperidol. Psychopharmacology. 77: 360-6. PMID 6813898 DOI: 10.1007/BF00432771  0.47
1981 Rebec GV, Alloway KD, Curtis SD. Apparent serotonergic modulation of the dose-dependent biphasic response of neostriatal neurons produced by D-amphetamine. Brain Research. 210: 277-89. PMID 6452929 DOI: 10.1016/0006-8993(81)90901-X  0.751
1981 Rebec GV, Alloway KD, Bashore TR. Differential actions of classical and atypical antipsychotic drugs on spontaneous neuronal activity in the amygdaloid complex. Pharmacology, Biochemistry, and Behavior. 14: 49-56. PMID 6110210 DOI: 10.1016/0091-3057(81)90102-7  0.74
1980 Rebec GV, Bashore TR, Zimmerman KS, Alloway KD. Neostriatal and mesolimbic neurons: dose-dependent effects of clozapine. Neuropharmacology. 19: 281-8. PMID 7422081 DOI: 10.1016/0028-3908(80)90151-3  0.734
1980 Rebec GV, Segal DS. Apparent tolerance to some aspects of amphetamine stereotypy with long-term treatment. Pharmacology, Biochemistry, and Behavior. 13: 793-7. PMID 7193874 DOI: 10.1016/0091-3057(80)90209-9  0.471
1980 Rebec GV, Zimmerman KS. Opposite effects of D-amphetamine on spontaneous neuronal activity in the neostriatum and nucleus accumbens. Brain Research. 201: 485-91. PMID 7191347 DOI: 10.1016/0006-8993(80)91058-6  0.466
1979 Rebec GV, Segal DS. Enhanced responsiveness to intraventricular infusion of amphetamine following its repeated systemic administration. Psychopharmacology. 62: 101-2. PMID 108743 DOI: 10.1007/BF00426043  0.348
1979 Rebec GV, Bashore TR, Zimmerman KS, Alloway KD. "Classical" and "atypical" antipsychotic drugs: differential antagonism of amphetamine- and apomorphine-induced alterations of spontaneous neuronal activity in the neostriatum and nucleus accumbens. Pharmacology, Biochemistry, and Behavior. 11: 529-38. PMID 43515 DOI: 10.1016/0091-3057(79)90036-4  0.742
1978 Rebec GV, Segal DS. Dose-dependent biphasic alterations in the spontaneous activity of neurons in the rat neostriatum produced by d-amphetamine and methylphenidate. Brain Research. 150: 353-66. PMID 567085 DOI: 10.1016/0006-8993(78)90286-X  0.414
1978 Bashore TR, Rebec GV, Groves PM. Alterations of spontaneous neuronal activity in the caudate-putamen, nucleus accumbens and amygdaloid complex of rats produced by D-amphetamine. Pharmacology, Biochemistry, and Behavior. 8: 467-74. PMID 209478 DOI: 10.1016/0091-3057(78)90086-2  0.676
1976 Rebec GV, Groves PM. Enhancement of effects of dopaminergic agonists on neuronal activity in the caudate-putamen of the rat following long-term d-amphetamine administration. Pharmacology, Biochemistry, and Behavior. 5: 349-57. PMID 996066 DOI: 10.1016/0091-3057(76)90088-5  0.675
1976 Groves PM, Rebec GV. Biochemistry and behavior: some central actions of amphetamine and antipsychotic drugs. Annual Review of Psychology. 27: 91-127. PMID 773267 DOI: 10.1146/annurev.ps.27.020176.000515  0.614
1975 Groves PM, Rebec GV. Alteration of the effects of (+)-amphetamine on neuronal activity in the striatum following lesions of the nigrostriatal bundle. Neuropharmacology. 14: 369-76. PMID 1153088 DOI: 10.1016/0028-3908(75)90019-2  0.622
1975 Rebec GV, Groves PM. Apparent feedback from the caudate nucleus to the substantia nigra following amphetamine administration. Neuropharmacology. 14: 275-82. PMID 1128762 DOI: 10.1016/0028-3908(75)90073-8  0.599
1975 Rebec GV, Groves PM. Differential effects of the optical isomers of amphetamine on neuronal activity in the reticular formation and caudate nucleus of the rat. Brain Research. 83: 301-18. PMID 1109301 DOI: 10.1016/0006-8993(75)90938-5  0.655
1975 Groves PM, Wilson CJ, Young SJ, Rebec GV. Self-inhibition by dopaminergic neurons. Science (New York, N.Y.). 190: 522-8. PMID 242074 DOI: 10.1126/Science.242074  0.689
1975 Groves PM, Rebec GV. Alteration of the effects of (+) amphetamine on neuronal activity in the striatum following lesions of the nigrostriatal bundle Neuropharmacology. 14: 5-6/.  0.622
1974 Groves PM, Rebec GV. The action of D-amphetamine on spontaneous activity in the caudate nucleus and reticular formation of the rat. Behavioral Biology. 11: 33-47. PMID 4364308 DOI: 10.1016/S0091-6773(74)90158-8  0.637
1973 Groves PM, Miller SW, Parker MV, Rebec GV. Organization by sensory modality in the reticular formation of the rat. Brain Research. 54: 207-24. PMID 4709145 DOI: 10.1016/0006-8993(73)90045-0  0.507
Show low-probability matches.